Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2015

O-Sullivan IS, Zhang W, Wasserman DH, Liew CW, Liu J, Paik J, et al. FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization. Nat Commun. 2015;6:7079.

Young LM, Marzio A, Perez-Duran P, Reid DA, Meredith DN, Roberti D, et al. TIMELESS Forms a Complex with PARP1 Distinct from Its Complex with TIPIN and Plays a Role in the DNA Damage Response. Cell Rep. 2015;13(3):451-459.

Carvalho FL, Marchionni L, Gupta A, Kummangal BA, Schaeffer EM, Ross AE, et al. HES6 promotes prostate cancer aggressiveness independently of Notch signalling. J Cell Mol Med. 2015;19(7):1624-36.

Jahangir S, Loya A, Siddiqui MT, Akhter N, Yusuf MA. Accuracy of diagnosis of solid pseudopapillary tumor of the pancreas on fine needle aspiration: A multi-institution experience of ten cases. Cytojournal. 2015;12:29.

Minton DR, Fu L, Chen Q, Robinson BD, Gross SS, Nanus DM, et al. Analyses of the transcriptome and metabolome demonstrate that HIF1α mediates altered tumor metabolism in clear cell renal cell carcinoma. PLoS One. 2015;10(4):e0120649.

Schulz TF, Cesarman E. Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesis. Curr Opin Virol. 2015;14:116-28.

Heymann JJ, Halligan AM, Hoda SA, Facey KE, Hoda RS. Fine needle aspiration of breast masses in pregnant and lactating women: experience with 28 cases emphasizing Thinprep findings. Diagn Cytopathol. 2015;43(3):188-94.

Gkrouzman E, Kirou KA, Seshan SV, Chevalier JM. Minimal Change Disease as a Secondary and Reversible Event of a Renal Transplant Case with Systemic Lupus Erythematosus. Case Rep Nephrol. 2015;2015:987212.

Subramaniyam S, Magro CM, Gogineni S, Tam W, Mathew S. Primary cutaneous follicle center lymphoma associated with an extracutaneous dissemination: a cytogenetic finding of potential prognostic value. Am J Clin Pathol. 2015;144(5):805-10.

Courtney KD, Manola JB, Elfiky AA, Ross R, Oh WK, Yap JT, et al. A phase I study of everolimus and docetaxel in patients with castration-resistant prostate cancer. Clin Genitourin Cancer. 2015;13(2):113-23.